Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7408 p35-41
8 July 2006

This section
Reprint   Photocopy

PDF 150K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

Pages: 35   36   37   38   39   40   41

35Central role in primary care remains a long way off There is a long way to go before a more central role in primary care is created for community pharmacists in England
PJ 2006;277:35
Full Text

35 Innovative pharmacists need followers or their efforts will be wasted Pharmacists with innovative ideas need to ensure that others are following their lead or they risk squandering their efforts
PJ 2006;277:35
Full Text

35 Boots and Alliance UniChem merger approved at EGMs Boots Group Plc and Alliance UniChem’s proposed merger was approved at extraordinary general meetings held by both companies
PJ 2006;277:35
Full Text


36 Latest chlamydia figures reveal 5 pc increase in UK Diagnoses of chlamydia increased by 5 per cent in the UK last year, figures released by the Health Protection Agency reveal
PJ 2006;277:36
Full Text

36 Emergency hormonal contraception prices fall with reduction in VAT The price of emergency hormonal contraception (EHC) is set to drop by around £3, after the Government’s promised VAT reduction came into
PJ 2006;277:36
Full Text

36 Redefine “practising” says College of Pharmacy Practice in Section 60 Order response “Practising” needs to be differently defined in the planned Section 60 Order on the future regulation of pharmacy, the College of Pharmacy Practice has said
PJ 2006;277:36
Full Text


37 Pharmacists have a significant role to play in PBC The role that pharmacists can play within practice-based commissioning (PBC) is the subject of the latest PBC bulletin published by Primary Care Contracting
PJ 2006;277:37
Full Text

37 LIFT services given the third degree The implementation of NHS local improvement finance trusts (LIFT) has been scrutinised by the House of Commons Committee of Public Accounts
PJ 2006;277:37
Full Text

37 Co-operative Group expands making it fourth largest chain Co-operative Group Pharmacy announced this week that the company has acquired another 40 pharmacies, making it the UK’s fourth largest pharmacy chain
PJ 2006;277:37
Full Text

37 Software used for clinical decision making needs to be regulated Unless governments start to regulate computer software used to make clinical decisions, negligence cases will end up deciding how such software should be validated, an editorial in The Medical Journal of Australia argues
PJ 2006;277:37
Full Text


38 Flu vaccine delay expected, so prioritise patients Initial deliveries of influenza vaccine for the 2006–07 season could be insufficient to meet demand, with subsequent supplies delayed, a UK Vaccine Industry Group (UVIG) statement has warned
PJ 2006;277:38
Full Text

38 Intrathecal analgesic to be launched next week A new intrathecal analgesic called ziconotide (Prialt) will be launched by Eisai
PJ 2006;277:38
Full Text

38 Trial shows diphenhydramine does not help infants sleep Diphenhydramine is no more effective than placebo at reducing night-time wakenings or improving parental happiness with sleep in infants aged six to 15 months
PJ 2006;277:38
Full Text

38 GPs urged to open pharmacies to make profit without extra work GPs have been urged to open pharmacies as a way of making big profits “without demanding much extra work”
PJ 2006;277:38
Full Text


39 Italy falls foul of European pharmacy ownership law Italy is to be taken before the European Court of Justice by the European Commission (EC) because it has national rules that prevent wholesalers buying government-owned pharmacies that are being denationalised
PJ 2006;277:39
Full Text

39 Orphan drug system works, Europe concludes Europe’s orphan drug incentive programme has led to 22 new products being licensed for 20 rare conditions in the five years that the system has been in existence
PJ 2006;277:39
Full Text

39 FDA issues safety alerts for tipranavir and telithromycin Safety alerts for tipranavir (Aptivus) and telithromycin (Ketek) have been issued by the US Food and Drug Administration
PJ 2006;277:39
Full Text

39 Pfizer to sell OTC business to J&J Pfizer has reached an agreement to sell its consumer health care business to Johnson & Johnson
PJ 2006;277:39
Full Text

39 Cegedim Rx and Enigma Health Cegedim Rx and Enigma Health will now both trade as Cegedim Rx
PJ 2006;277:39
Full Text

39 Public health support NHS Education for Scotland has published a package to support the implementation of the public health aspects of the new pharmacy contract in Scotland
PJ 2006;277:39
Full Text


40 Small weight loss achieved after switching to long-acting insulin People with diabetes who switch to the longacting insulin analogue detemir (Levemir) may benefit from fewer insulin-associated side effects such as weight gain
PJ 2006;277:40
Full Text

40 Increased cardiovascular risk linked with clozapine Patients taking clozapine are at an increased risk of developing metabolic syndrome
PJ 2006;277:40
Full Text

40 Perioperative beta blockade Compared with placebo, sustained release metoprolol given to patients with diabetes undergoing non-cardiac surgery does not affect long-term mortality and cardiac morbidity, say researchers
PJ 2006;277:40
Full Text


41 Fortnightly cetuximab an option for colon cancer Patients could be spared the necessity of making weekly journeys to oncology units for cetuximab (Erbitux), a targeted treatment for metastatic colorectal cancer, according to a new study that shows fortnightly infusions with a higher dose are equally safe and effective
PJ 2006;277:41
Full Text

41 Lord Warner endorses BNF-C The BNF for Children, published by the Royal Pharmaceutical Society and the British Medical Association, has been praised by health minister Lord Warner
PJ 2006;277:41
Full Text

41 CBT superior to zopiclone in small sleep trial Cognitive behavioural therapy is superior to zopiclone treatment for short- and long-term management of insomnia in older adults, according to research published in JAMA
PJ 2006;277:41
Full Text

Back to Top


©The Pharmaceutical Journal